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Abstract
Infective endocarditis is associated with significant cardiac and noncardiac morbidity.
Among many complications, septic embolism has the potential of causing devastating
sequelae and even life-threatening clinical situations. This dreaded clinico-pathologic
entity is characterized by its heterogeneous presentation and the ability to affect various
body  systems  and  organs.  Septic  emboli  to  the  brain,  kidneys,  spleen,  and  the
pulmonary system constitute the vast majority of metastatic infections. However, other
organ  systems  can  also  be  affected.  This  chapter  provides  an  overview  of  septic
embolism  associated  with  infective  endocarditis,  focusing  on  key  diagnostic  and
therapeutic considerations in the most commonly seen and clinically relevant scenarios.
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1. Introduction
The importance of septic embolism (SE) associated with infective endocarditis (IE) is both
under-appreciated and under-stated [1, 2]. In one large series, systemic arterial embolization
or septic pulmonary infarction occurred in approximately 33% and 11% of cases, respectively
[1]. Although mortality attributable to IE can exceed 30% [1, 3], it is even higher among patients
who experienced SE events [4]. Accurate and timely identification of IE and SE is of critical
importance because the presence and type of SE is one of the most important factors taken
into consideration when formulating a treatment strategy. Sound clinical judgment and a high
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index of suspicion are required as the diagnosis of IE and SE is not based on a single test but
rather on the combination of clinical findings and diagnostic studies. Microbiologic studies
guide antimicrobial therapy. Advanced imaging, including computed tomography (CT) and
magnetic resonance imaging (MRI), is used to identify both the extent and location(s) of
postembolic  infarcts  or  abscesses.  Surgical  management,  both cardiac and noncardiac,  is
beyond the scope of the current chapter and is discussed elsewhere in this comprehensive
textbook.
2. Infective endocarditis and septic embolism: general clinical, diagnostic
and treatment considerations
2.1. General clinical and microbiological considerations
The estimated crude annual incidence of IE is approximately 1 case per 33,000 population, with
peak incidence among men between the ages of 70 and 80 years (approximately 1 in 6,900) [1].
Infective endocarditis is a predominantly male disease (50–65% patients) with mean age at the
time of presentation between 52 and 63 years, depending on the causative microorganism [1,
3]. Major risk factors for IE include underlying heart disease, cardiac surgery and interven-
tional procedures, prosthetic valve, intravenous drug use, immunosuppression, dental
infections, and previous infective endocarditis [1, 3, 5]. Alimentary, genitourinary, respiratory
tract, orthopedic, and skin infections, as well as pregnancy-related infection events have also
been associated with IE, although far less commonly [3, 6]. Mortality ranges between 6% and
30%, again depending on patient factors and the microorganism(s) involved [1, 3]. Of note,
mortality rate was noted to be higher (20%) among patients with IE who experienced embolic
or “metastatic” events when compared to individuals without such occurrences (12%) [4].
Clinical presentation of IE involves the development of fever in >90% of cases, with approxi-
mately one out of three affected patients experiencing congestive heart failure [1]. Heart
murmurs can be present, but may be more reflective of primary valvular disease rather than
IE itself [7]. Elevated serum creatinine suggesting renal failure may be present in >25% of cases,
and approximately 10% of patients develop septic shock [1]. Rarely, associated life-threatening
events such as cardiac tamponade have been reported [8]. According to large clinical series on
IE, the most commonly encountered bacteria include Staphylococci (19–29% cases), Streptococci
(44–48%), Enterococci (8–19%), Gram-negative organisms, (5–7%), polymicrobial occurrences
(0.7–3%), with 5–10% of cases having no microorganisms identified (also known as “culture
negative” endocarditis) [1, 3]. Of importance, nosocomial/iatrogenic cases of IE are more likely
to be associated with staphylococcal infection when compared to community-acquired IE (35%
versus 21%, respectively) [1].
2.2. Pathophysiologic considerations
Septic embolism is most commonly associated with IE, septic thrombophlebitis, periodontal
and various systemic infections, as well as central venous catheter and implanted device
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infections [2]. The combination of aging population, implantable device miniaturization, and
the emergence of multi-morbidity have all synergistically contributed to the increased risk of
both IE and SE [2, 9]. Thrombogenic characteristics associated with intravascular infections,
combined with the relative lack of antibiotic efficacy to clear bloodstream infections, result in
elevated risk of SE [10]. According to Millaire et al. [4], embolic events may occur in >50% of
IE cases. Fortunately, such events are not associated with significant attributable mortality
when properly managed [4]. Further focusing on the cardiac etiology of SE, one of the largest
series reported that embolization to the central nervous system was seen in approximately 20%
cases of mitral valve IE, 15% cases of aortic valve IE, and 18% combined cases of aortic and
mitral IE [1]. When examining right-sided endocarditis, 68% of cases were associated with
pulmonary embolization [1]. Finally, it is important to recognize that IE is distinct from
nonbacterial thrombotic endocarditis—a pathologic entity that can also result in distal
embolization and is beyond the scope of the current chapter [11].
2.3. Septic embolization by anatomic location
When examining the anatomic distribution of nonpulmonary SE in the setting of IE, the most
commonly affected organs and organ systems included the central nervous system (48–65%),
extremities (30%), spleen (19–32%), and kidney (6–14%) [1, 4, 12]. Less commonly affected
structures/organs included the lung (14%), coronary vessels (6%), the liver (3–11%), bone and
joint structures (11%), iliac arterial system (6%), and mesenteric arteries (3%) [1, 2, 4]. From
anatomic standpoint, a special and more “diffuse” category of embolic events includes
musculoskeletal manifestations, which are thought to occur in as many as 44% of cases of SE
[13]. Due to their self-limiting nature and nonspecific manifestations (e.g., arthralgias, myal-
gias, back pain, arthritis), this category of events is often under-reported and tends to be
Figure 1. Diagram showing the anatomic distribution of septic emboli in the setting of infectious endocarditis. Com-
piled from multiple literature sources [1, 2, 4, 12–14].
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neglected [14]. Figure 1 summarizes the anatomic distribution of septic emboli in the setting
of IE [1, 2, 4, 12–14]. Of note, anatomic distribution of septic emboli associated with infective
endocarditis (48–65% cerebral, 35–52% noncerebral [1, 2, 4]) approximates that of valvular
atrial fibrillation (56–63% cerebral, 38–44% noncerebral [15, 16]) suggesting that structural
anatomic factors play a role in the pathophysiology of emboli originating from cardiac valves
[16–18].
2.4. Diagnostic considerations
Diagnosis of SE requires high index of clinical suspicion, combined with accurate identification
and recognition of IE as a source. In the setting of native heart valves, trans-thoracic echocar-
diography (TTE) should be performed as an initial screening test [19]. If results of the TTE are
negative, IE can usually be ruled out if Duke criteria suggest low probability [20, 21]. However,
if Duke criteria suggest high suspicion of IE, or if TTE is positive or suspicious for IE, or the
patient has a prosthetic valve, the next diagnostic step should be the performance of trans-
esophageal echocardiography (TEE) [7, 19–21]. If the TEE is positive, the diagnosis is con-
firmed. However, if negative, the test can be repeated in 1–2 weeks if clinical suspicion
continues to be high [19]. If the above diagnostic steps continue to produce negative results,
alternative diagnosis should be entertained.
Multiple, repeated blood culture determinations are often required to identify the causative
organism. Although microbiological studies provide critical information regarding targeted
antibiotic therapy in IE, results are not always immediately available or universally accurate
[22, 23]. Among more recent developments, real-time polymerase chain reaction (PCR) is more
sensitive and specific in addition to providing clinically relevant results quickly [24]. Initial
antimicrobial coverage should be broad, and once the involved microorganism is identified
and antibiotic susceptibilities are known, the therapy can be appropriately narrowed to
optimize long-term management. When SE is suspected, advanced imaging (CT and/or MRI)
constitutes the cornerstone of confirmatory testing [2, 14, 25, 26].
2.5. Therapeutic considerations
Infective endocarditis complicated by SE requires a multidisciplinary, multimodality thera-
peutic approach. As outlined in previous sections, broad-spectrum antibiotic management is
the most important initial step in management of both IE and SE. Once the offending micro-
organism is confirmed by microbiological testing, antibiotic coverage should be narrowed
according to established sensitivity data. The decision to proceed with cardiac surgical therapy
of IE is a complex one, most indications are not absolute, and pertinent decision-making is
discussed elsewhere in this text. When cardiac surgery is indicated, early intervention has been
associated with decreased all-cause mortality (including deaths following SE) due largely to
the lower risk of subsequent systemic embolization [27]. When SE is present, the type and
location of emboli guides the treatment strategy. Other surgical and interventional procedures
may be utilized to treat complications resulting from SE, including vascular or endovascular
interventions for arterial aneurysms [2, 28, 29], percutaneous drainage of abscesses [2], or organ
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resections (i.e., splenectomy or bowel resection) for infarctions and/or refractory infections [30,
31].
3. Septic emboli to central nervous system
Neurologic complications are a hallmark of left-sided IE and contribute to its unfavorable
prognosis [32, 33]. The reported incidence of SE is likely underestimated [4, 34]. In the absence
of abnormal intracardiac communication, neurological symptoms develop secondary to
emboli originating from left-sided valvular vegetations (Figure 2) [1]. Less commonly,
neurologic complications can also occur in cases of right-sided endocarditis with patent
foramen ovale or other atrial septal defects [35]. A major risk factor for SE to the central nervous
system is the delay or lack of appropriate antibiotic therapy [36]. In one study, the incidence
of stroke decreased from 4.82 per 1000 patient-days to 1.71 per 1000 patient-days between the
first and second weeks of appropriate antimicrobial therapy, respectively [37]. Other risk
factors for septic cerebral embolism include vegetation size >10 mm, mobile and multiple
vegetations, mitral and/or aortic valve endocarditis, preoperative empiric antibiotic therapy,
annular abscess, anticoagulant therapy at the time of IE diagnosis, and the causative organ-
ism being Staphylococcus aureus [37–43]. Of note, SE to the spleen and kidneys commonly co-
occur in patients with cerebral emboli [39].
Figure 2. Echocardiography showing large (1.8 × 1.6 cm) mitral valve vegetation (arrows).
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Clinical manifestations may include ischemic stroke (Figure 3), transient ischemic attack (TIA),
cerebral hemorrhage, meningitis, brain abscess, encephalopathy, and mycotic aneurysms [38,
39, 42, 44, 45]. Taken together, these complications often occur early (within the first 7 days of
IE) and negatively impact patient outcomes [46]. Among all neurologic manifestations of IE,
ischemic stroke and TIA are the most common (16–50% of all occurrences) [38, 39, 44, 45, 47–
49]. In approximately 70% of patients with SE of the central nervous system, the middle cerebral
artery distribution is involved [38, 44]. Focal neurological symptoms (hemiparesis, facial
droop, diplopia, aphasia, vertigo) are present in approximately 40% of affected patients, and
nonfocal presentations (headaches, seizures, altered mental status) occur in approximately
one-third of cases, with roughly one in five patients remaining asymptomatic [40]. Evaluation
should include MRI with and without gadolinium, or CT with and without contrast if MRI is
not possible. Vascular imaging should be performed routinely, and CTA or MRA is probably
sufficient for screening, with catheter angiography reserved for cases where a mycotic
aneurysm was noted and in those patients with an acute brain hemorrhage [50].
Figure 3. Magnetic resonance imaging (MRI) showing septic embolus to the brain. Source: Stawicki et al. [2]. Used un-
der the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unre-
stricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
A relatively less common manifestation of SE associated with IE is bacterial meningitis, usually
presenting with fever, neck stiffness, and altered mental status [51]. The most common
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causative bacterial species are Streptococcus pneumoniae (54%) and Staphylococcus aureus (33%)
[51]. The diagnosis is confirmed via cerebrospinal fluid analysis, and management requires
long-term antibiotic administration and control of the septic source [44, 51].
In addition to being associated with worse clinical outcomes, neurologic complications of SE
often force the alteration in therapeutic plans for IE, including the timing/type of operative
intervention and the duration of antibiotic treatment [42, 46–49]. Neurological complications
negatively impact clinical outcomes, with mortality as high as 45% (compared to 24% in
patients who did not experience neurologic sequelae) [43]. Cerebral hemorrhage and moder-
ate-to-severe ischemic events are the main determinants of mortality [43]. Early and appro-
priate antibiotic therapy remains the cornerstone of IE management and a major preventive
strategy to reduce SE to the brain [52]. Although thrombolysis has been traditionally contra-
indicated for ischemic stroke in the setting of IE due to the risk of massive cerebral hemorrhage
[53], some authors have reported good outcomes with thrombolytic therapy in selected cases
[44, 54]. Having said that, rates of intracerebral hemorrhage following thrombolysis in such
circumstances may be as high as 20% [55].
The use anticoagulation may increase the risk of cerebral hemorrhage without appreciable
reduction in the incidence of embolic events, and, as of now, there is no evidence to support
this practice [43]. Likewise, antiplatelet agents (including aspirin) were not found to be
beneficial in preventing the occurrence of embolic events in a double-blinded, placebo
controlled trial [56]. It is recommended to discontinue anticoagulation for at least 2 weeks in
patients with IE who develop central nervous system embolic complications regardless of the
other indications for anticoagulation, including the presence of mechanical heart valves. The
final decision regarding anticoagulation and antiplatelet therapy should be made by a
multidisciplinary team including cardiologist, cardiac surgeon, and neurologist [57, 58].
Although uncommon, intracranial mycotic aneurysms are among the most dreaded compli-
cations of IE with mortality as high of 16–30% in unruptured cases and 49–80% in ruptured
ones [58, 59]. The presentation is variable, with some patients remaining asymptomatic while
others developing focal neurologic signs, meningitis, subarachnoid, or intraventricular
hemorrhage [58]. Approximately one in five patients may have multiple aneurysmal lesions
[60]. Unruptured mycotic aneurysms should be serially monitored and treated conservatively
with antibiotic therapy [61]. The treatment of a ruptured cerebral mycotic aneurysm depends
on its location, as well as the presence or absence of any associated mass effect [61, 62].
Indications for valvular surgical intervention include, but are not limited to: new severe
valvular regurgitation, congestive heart failure, large vegetation (>10 mm), abscess formation,
persistently positive blood cultures or emboli despite appropriate antibiotic therapy, prosthetic
valve dehiscence, or the presence of highly resistant organisms [63, 64]. Although most patients
continue to have an indication for valve surgery after a cerebral SE [47], the timing of cardiac
surgery is controversial because the hemorrhagic conversion of an ischemic brain lesion in the
setting of intraoperative anticoagulation can be devastating [65–67]. The traditional recom-
mendation is to postpone cardiac surgery for at least 4 weeks [65–67]. The relatively uncommon
nature of hemorrhagic conversion of preoperative brain lesions has led some to consider earlier
operative therapy in acute IE, hoping to prevent deaths that otherwise would have occurred
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during the 1 month delay, as well as reducing further embolic events that can cause permanent
disability [39]. As a result, evidence is emerging that early operative treatment for patients
with nonhemorrhagic cerebral embolic events does not lead to worse outcomes. In a recent
report, 198 patients undergoing valve replacement following cerebral infarction were analyzed
with 58 undergoing early surgery (1–7 days) and 140 undergoing late surgery (>7 days). There
was no survival benefit in delaying otherwise indicated surgery for IE among patients with
cerebral SE [68]. Another retrospective study reviewed operative results of 308 patients with
IE, finding no difference in key outcomes (postoperative stroke, 30-day mortality, long-term
survival) when comparing patients with cerebral SE undergoing early surgery (<14 days) to
patients undergoing surgery for IE without cerebral complications [40]. However, some
authors report that early cardiac surgery is associated with neurological complications [43].
Both the American Heart Association and The Society of Thoracic Surgeons workforce on
evidence-based surgery report that it is probably safe to proceed with an early operation in
patients with small ischemic infarction, while delaying a surgery for 2–4 weeks might be
preferred for those with a large ischemic infarction or a hemorrhagic event, respectively. In
those with worsening cardiac function, recurrent stroke, uncontrolled infection or recurrent
emboli, a delay of less than 4 weeks may be reasonable [50, 58].
4. Septic embolism to the kidneys
Despite numerous case reports, available clinical data on SE to the kidneys continue to be
limited [2, 69–71]. Embolic events associated with IE involve kidneys in 6–14% cases (Fig‐
ure 1) and exhibit highly variable pattern of presentation [2, 69]. Most patients complain of an
acute onset of abdominal, flank, or back pain. The pain is typically constant. Approximately
half of reported cases present with fever and vomiting. Acute secondary hypertension from
renin release due to decreased arterial perfusion may be seen. Laboratory findings may include
leukocytosis, proteinuria, hematuria, elevated levels of lactate dehydrogenase, serum gluta-
mic-oxaloacetic transaminase, serum glutamic-pyruvic transaminase, and alkaline phospha-
tase [70]. Potential complications of septic emboli include hematuria, glomerulonephritis, or
infarction leading to loss of renal function. Three types of severe renal manifestations may be
seen: renal infarcts, focal “embolic” glomerulonephritis, and acute diffuse glomerulonephritis
[72]. Renal loss due to embolic occlusion of the renal artery has been reported [71]. Of interest,
localized renal infarcts were found in over 30% of necropsy samples, with more than half
attributable to SE in patients infected with Staphylococcus aureus [69]. Renal SE and infarction
may be associated with concurrent embolic events to other organs (Figure 4) [73]. In one
reported case, renal infarction was found in conjunction with SE to the coronary arteries and
the spleen [74]. In another case, multiple acute SE infarcts due to Gram-positive aortic valve
IE were found in the brain, spleen, kidneys, and the intestine [75]. Treatment is usually
supportive, consisting of systemic antibiotics, renal replacement therapy (if indicated) [69],
and only rarely involves percutaneous or open procedural interventions [14, 76]. Preservation
of renal function is the primary goal.
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Figure 4. The presence of simultaneous renal (A) and splenic (B) infarctions secondary to septic embolism. Source:
Modified from Grob et al. [73]. Used under the terms of the Creative Commons Attribution License (http://creative-
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provid-
ed the original work is properly cited.
5. Septic embolization to spleen
Splenic involvement is often seen in the setting of left-sided valvular vegetations from IE [12].
The two primary manifestations are splenic infarction (most common) and splenic abscess.
Although often asymptomatic, splenic infarct may be associated with acute abdominal
(usually left upper quadrant) pain and can be complicated by abscess formation (the primary
source of subsequent morbidity and mortality) [12, 77]. Splenic abscess formation is due to
hematogeneous spread from a distant source of infection, with IE being associated with up to
two-thirds of such instances, either via bacteremic seeding or direct embolization of infected
valvular debris [78, 79].
In one study, splenic infarcts were found in 19% of cases of IE, including asymptomatic cases
identified on CT examination [12]. Streptococci and staphylococci are among the most common
offending microorganisms, accounting for >80% of cases [4, 12]. While Streptococcus viridans
and Staphylococcus aureus are frequently encountered, other bacterial species including K.
pneumoniae, S. epidermidis, and P. mirabilis have been described in this setting [79].
Because mortality associated with splenic abscess is high, prompt and appropriate therapy is
critical. Management includes antibiotics based on microbial sensitivity, image-guided
aspiration or drainage, and surgical intervention by splenectomy (open or laparoscopic) in
selected cases [80–83]. Early detection may help reduce the need for surgical intervention.
Although the identification of SE to the spleen does not constitute a surgical indication, the
presence of an abscess refractory to nonoperative approaches (e.g., antibiotics with or without
percutaneous drainage), uncontained abscess rupture, or the presence of vascular complica-
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tions (e.g., pseudoaneurysm or a large infarction) should prompt the consideration of sple-
nectomy [84–87]. Likewise, refractory pain may also constitute a surgical indication (or be a
clinical warning sign of one of the above complications) [80, 87, 88]. The decision to operate in
the setting of therapeutic uncertainty should be considered in the context of the simultaneous
presence of any other relative indications, risks, and benefits. The diagnosis of splenic infarct
is not a contraindication for a cardiac operation when such intervention is indicated. The
situation is not as clear in the presence of a splenic abscess. In most cases, it is preferable to
perform splenectomy prior to valve surgery in order to prevent re-infection of the valve
prosthesis or annuloplasty ring [58, 89]. Combined cardiac procedure and splenectomy has
been reported with good outcomes [90].
6. Septic emboli to mesenteric vasculature
Septic embolization to the mesenteric vessels is a serious, potentially life-threatening compli-
cation of IE [4]. Small valvular vegetations can break off, enter the circulation, and become
lodged in the mesentric arteries, endangering blood supply to the small intestine and colon
[91, 92]. Compared to other organ systems affected by metastatic or embolic events of IE,
mesenteric embolization is relatively rare, constituting approximately 3% of SE [2]. However,
general surgeons must consider this entity on their differential list of causes leading to acute
bowel ischemia. In terms of vascular distribution, the inferior mesenteric artery (IMA)
involvement is much less common than SE to the superior mesenteric artery (SMA, approxi-
mately 3% versus <1%, respectively) [93]. Clinical indications for operative abdominal
intervention following mesenteric SE are similar to those for other acute abdominal emergen-
cies and have been discussed elsewhere [94, 95].
Septic embolism involving the mesenteric vessels can also be associated with mycotic aneur-
ysms [96]. Pathophysiology involves embolization of small valvular vegetation fragments to
the arterial vasa vasorum or the intraluminal space with subsequent extension of the infection
through the intima and outward through the media of the vessel wall [58, 97]. This process
gradually weakens the arterial wall, resulting in pathologic dilation and pseudoaneurysm
formation [58]. Depending on the anatomic characteristics of the pseudoaneurysm, and the
presence versus absence of associated distal embolization/thrombosis, management may
include resection or vascular bypass of the lesion [98]. Inherent to the nature of pseudoaneur-
ysms secondary to SE, high complication rate and/or mortality may be encountered [98].
In one unusual case, Streptococcus bovis endocarditis was reported to be associated with SE to
the superior mesenteric artery (SMA) resulting in a mycotic aneurysm. Computed tomography
(CT) imaging demonstrated a saccular aneurysm of the SMA and follow-up angiography
showed evidence of SE to the left femoral artery [99]. A duplex ultrasound further character-
ized the femoral artery lesion as an intravascular mass at the left femoral artery bifurcation.
Echocardiography confirmed mitral valvular vegetations. The patient underwent surgical
resection of the mesenteric aneurysm, embolectomy of the femoral artery, as well as mitral
valve replacement procedure [99].
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In another report, Coxiella burnetii endocarditis led to concurrent SMA embolism and renal
infarction. The patient presented with acute abdominal and flank pain, with subsequent CT
of the abdomen demonstrating acute infarct of the right kidney and suspected SMA emboli
[100]. The patient underwent laparotomy and successful SMA balloon thromboembolectomy.
Subsequent TEE demonstrated a heterogeneous, mobile aortic valve mass. The patient was
started on triple antibiotic regimen of vancomycin, gentamicin, and ceftriaxone. Subsequent
aortic valve replacement was performed using a pericardial valve, with good long-term clinical
outcome [100].
7. Right‐sided endocarditis and septic pulmonary embolism
Right-sided IE (Figure 5) usually manifests as persistent fevers, bacteremia, and multiple septic
pulmonary emboli (SPE, Figure 6). Isolated pulmonary valve endocarditis accounts for only
about 2% of IE cases [101]. Due to its rarity, SPE is often difficult to diagnose due to its
nonspecific presentation. In addition to the signs and symptoms of IE, SPE may cause pleuritic
chest pain, cough, and/or hemoptysis [102] and may be complicated by pulmonary infarction,
abscess, pneumothorax, pulmonary infiltrates, and purulent pulmonary effusion [103–105].
Although rare, right-sided heart failure due to increased pulmonary arterial pressure or severe
right-sided valvular regurgitation/obstruction may occur. Historically, SPE was associated
with intravenous drug use [106]. However, today the most common clinical risk factors include
indwelling intravascular catheters, intravascular devices, and noncardiac sources of sepsis,
especially in hospitalized patients [107–110].
Figure 5. Echocardiographic images of tricuspid valve endocarditis characterized by the presence of a large vegetation
(arrows).
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Figure 6. Septic pulmonary emboli associated with tricuspid valve endocarditis due to methicillin-resistant Staphylo-
coccus aureus. Source: Stawicki et al. [2]. Used under the terms of the Creative Commons Attribution-Noncommercial-
Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited.
Regarding diagnostic modalities used in the setting of suspected SPE, chest radiography is
nonspecific and usually shows poorly marginated peripheral lung nodules, possibly with
cavitary features [25]. Computed tomography provides much better image granularity and
usually demonstrates bilateral nodules or multifocal infiltrates, often involving peripheral
lung zones and associated cavitary lesions [102]. These features, in conjunction with extrap-
ulmonary infection, should raise suspicion of SPE as the underlying cause. The “feeding
vessel” sign, or the finding of a vessel which projects into a peripheral lung lesion, is fairly
specific for SPE [111, 112]. Patients with SPE and suspected IE should undergo echocardiog-
raphy to rule out valvular infection and to assess for any associated cardiac complications [113,
114]. TEE is preferred over TTE due to better image resolution and improved diagnostic
accuracy for detecting small vegetations, abscesses, and leaflet perforations up to 5 mm in size
[113, 114].
A conservative approach is recommended in most patients with right-sided IE because
significant majority of the cases will resolve with antimicrobial therapy alone [115, 116]. The
role of surgery remains unclear because the presence of SPE and/or recurrent SPE is not an
absolute indication for operative intervention. Surgery is usually indicated in cases of persis-
tent sepsis, lack of response to appropriate antimicrobial therapy, right heart failure secondary
to severe tricuspid regurgitation, and persistent large vegetation [50, 58, 117, 118]. Thoraco-
scopy or thoracotomy may be required in complicated cases of SPE (e.g., empyema, pulmonary
abscess) [102, 106].
8. Additional considerations and special topics
Majority of the literature on IE and SE is devoted to the most common and clinically relevant
presentations, leading to a degree of “neglect” toward the unusual yet still potentially
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significant complications. In this section, the authors will discuss other, less common mani-
festations of SE. More specifically, we will focus on septic emboli to various anatomic locations,
in decreasing order of incidence.
8.1. Septic emboli to solid abdominal organs
A significant proportion of SE involves abdominal and retroperitoneal solid organs (e.g., liver,
spleen, pancreas, kidneys). Emboli to the more commonly affected locations (e.g., spleen and
kidney) have been discussed earlier in this manuscript. It is important to remember that septic
embolic phenomena tend to simultaneously involve more than one anatomic location, with
significant proportion of events being asymptomatic [75, 119]. At times, smaller septic embolic
lesions may coalesce to form well-defined abscesses [120]. The next two sections will discuss
hepatic and pancreatic SE occurrences.
8.2. Septic embolism to the liver
Liver abscesses due to SE associated with IE are well documented in the medical literature
[121]. As outlined above, larger hepatic abscesses may evolve over time from smaller, adjacent
microabscesses [120]. Infectious endocarditis should be entertained in the setting of any hepatic
abscess of uncertain etiology, with echocardiography undertaken in order to rule out cardiac
valvular source [122]. Clinical approach is usually multi-modal, including broad-spectrum
antibiotics, endoscopy, percutaneous drainage, and/or surgery [2].
8.3. Septic emboli to the pancreas
Pancreatic septic emboli have been described in the setting of multi-visceral SE [75]. Due to the
disproportionate severity of concurrent embolic events, pancreatic SE is likely under-reported
and under-appreciated. Clinical presentation of pancreatic SE may resemble that of pancrea-
titis (e.g., abdominal pain, elevated serum amylase/lipase, leukocytosis, and peri-pancreatic
inflammatory changes on advanced imaging) [2]. The range of possible clinical presentations
spans from that of self-limited pancreatitis to an overwhelming necrotizing infection. Associ-
ated findings may also include vascular abnormalities (e.g., pseudoaneurysms) involving
nearby vasculature (i.e., pancreaticoduodenal artery) on advanced imaging [123].
8.4. Coronary septic emboli
Coronary embolization from a septic focus has been relatively well reported in the literature
[74, 124] and usually originates from valvular vegetations in the setting of IE [125]. Septic
coronary embolism has also been reported to occur intraoperatively during mitral valve
surgery performed in the setting of IE [126]. Coronary arterial SE should be entertained in cases
of known or suspected left-sided IE and evidence of concurrent acute myocardial ischemia
(e.g., abnormal ECG or elevated cardiac enzymes). Echocardiography (preferably TEE) can
reliably demonstrate the presence of valvular vegetations, in addition to documenting other
changes characteristics of myocardial ischemia [127]. Coronary occlusion secondary to SE can
also be confirmed via coronary angiography, with the potential for percutaneous coronary
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intervention at the same time [128]. Acutely occluded major coronary arteries or branches may
require surgical revascularization at the time of valve surgery. Patients with aortic valve
endocarditis, in whom preoperative coronary angiography may be contraindicated due to
concerns of dislodging debris, may require empiric grafting [2]. An example of a mycotic
coronary artery aneurysm associated with IE is shown in Figure 7.
Figure 7. Mycotic aneurysm of the right coronary artery. The patient underwent venous bypass grafting. Source: Sta-
wicki et al. [2]. Used under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
8.5. Septic emboli to extremities
Distal septic emboli are well described in the setting of IE [30, 129]. A nontrivial proportion of
SE associated with IE requiring valvular replacement affects the extremities, with some
patients experiencing multiple embolic events [30, 129]. Clinical manifestations can vary from
extremity pain to limb-threatening ischemia [30]. In less severe cases, ischemic symptoms may
resolve with anticoagulation and antimicrobial therapy, while in more acute presentations
surgical embolectomy or even amputation may be required [30].
8.6. Arterial lesions associated with septic embolism
Secondary arterial changes and associated lesions have been reported in the setting of infec-
tious embolization [75, 130]. Inflammatory changes were noted in the walls of arteries adjacent
to an intracranial hematoma following septic embolization [75]. In one instance, brachial artery
pseudoaneurysm (Figure 8) has been described in the setting of severe prosthetic aortic valve
endocarditis [2]. In another case, a ruptured mycotic aortic abdominal aneurysm occurred in
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a child with SE following the resection of an infected cardiac myxoma [131]. Due to rarity of
such arterial lesions and the associated nonspecific clinical presentation(s), it is extremely
important to maintain a high index of suspicion when potential infections of arterial structures
are identified.
Figure 8. Large (2.5 cm) brachial artery pseudoaneurysm secondary to septic embolization from prosthetic aortic valve
endocarditis. Source: Stawicki et al. [2]. Used under the terms of the Creative Commons Attribution-Noncommercial-
Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited.
8.7. Uncommon presentations involving the central nervous system
Exceedingly rare, septic embolism may involve the spinal cord and lead to associated spinal
cord infarction [132, 133]. In such cases, other organs are likely to become involved as well,
including the kidneys and pulmonary circulation [132]. Finally, septic embolism to the retina
has been reported in the setting of staphylococcal tricuspid endocarditis in intravenous drug
abusers [119].
9. Conclusions
Despite significant evolution of both diagnostic and therapeutic approaches, septic emboli
continue to present a formidable challenge to the practicing clinician. In addition to high index
of suspicion and early clinical recognition, prompt identification of the offending cardiac
source and the institution of immediate goal-directed antibiotic therapy are all critical to
successful outcomes. More widespread awareness of risk factors, clinical presentations, and
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management of SE is needed, with added focus on preventing embolic events and the
management of associated complications.
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